特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
953671

Covid-19診断の世界市場:国別の需要見通し

Covid-19 Global Diagnostic Demand Outlook By Country. Assay Volume Quarterly Outlook To December 2021 Separately For Molecular and Serology. Updated to Include Q1 & Q2 2020 Actuals Data

出版日: | 発行: Howe Sound Research | ページ情報: 英文 214 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
Covid-19診断の世界市場:国別の需要見通し
出版日: 2020年07月25日
発行: Howe Sound Research
ページ情報: 英文 214 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、新型コロナウイルス感染症(COVID-19)診断法の市場について調査し、2020年第1四半期と第2四半期の実績データに基づいて2021年12月までの四半期ごとの国別需要見通しを明らかにしたもので、主要企業のプロファイルなどの情報も提供しています。

目次

i. COVID-19の戦略的状況分析

ii. 企業幹部向けガイダンス

iii. 経営コンサルタントと投資顧問向けのガイダンス

第1章 イントロダクションと市場の定義

  • パンデミックとは何か
  • 動物原性感染症の役割
  • 市場の定義
    • アッセイの量
    • 医療システムの需要
    • 分子と血清学
  • 調査手法
  • パンデミックの歴史的展望
    • HIV /AIDSパンデミック:2005-2012
    • インフルエンザパンデミック:1968
    • アジア風邪パンデミック:1956-1958
    • スペイン風邪: 1918
    • コレラの第6次パンデミック:1910-1911
    • インフルエンザパンデミック:1889-1890
    • 黒死病:1346-1353

第2章 パンデミックの概要

  • ウイルスとは
    • ウイルスは生きているのか
    • ウイルスの構造
    • ウイルスゲノム
    • ウイルス変異
  • コロナウイルス
    • 重症急性呼吸器症候群(SARS)
    • 中東呼吸器症候群(MERS)
    • COVID-19:SARS CoV 2ウイルス
  • パンデミック診断
    • リスク管理-活性化と蔓延
    • 診断技術-核酸ベース
    • 診断技術-イムノアッセイ
    • 市場投入までの時間と準備の問題

第3章 国別の感染/入院の予測(四半期別)

  • シナリオの概要
    • WHO Global Health Security Index
    • パンデミック進行の予測手法
  • シナリオ1.最良のケース
  • シナリオ2.予想されるケース
  • シナリオ3.最悪のケース

第4章 企業プロファイル

  • 1drop
  • Abbott Diagnostics
  • Accelerate Diagnostics
  • Ador Diagnostics
  • Advanced Biological Laboratories
  • Akkoni Biosystems
  • Altona Diagnostics
  • Alveo Technologies
  • Applied BioCode
  • Applied DNA Sciences
  • Anatolia Geneworks
  • Assurance Scientific Laboratories
  • Aus Diagnostics
  • Autobio Diagnostics
  • BD Diagnostics
  • BGI Genomics Co. Ltd
  • Biocartis
  • Biodesix
  • BioFire Diagnostics
  • Biolidics
  • bioMérieux
  • Bioneer
  • Bio-Rad Laboratories
  • BioReference Laboratories
  • Bosch Healthcare Solutions GmbH
  • Cepheid
  • Cerstest Biotec
  • Chembio Diagnostics
  • Color Genomics
  • Credo Diagnostics Biomedical
  • Curetis
  • Diagenode Diagnostics
  • Diascopic
  • Diasorin
  • Enzo Life Sciences, Inc.
  • Exact Sciences
  • Expedeon
  • Fulgent Genetics
  • Fusion Genomics.
  • Genedrive
  • GenePOC Diagnostics
  • Genetic Signatures
  • Genetron
  • GenMark Dx
  • Gold Standard Diagnostics
  • Hologic
  • Immunexpress
  • Inflammatix
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Laboratory Corporation of America
  • Lexagene
  • Luminex
  • Mayo Clinic Laboratories
  • Mbio Diagnostics
  • Meridian Bioscience
  • Mesa Biotech
  • Mobidiag
  • Nanomix
  • Novacyt
  • Orig3n
  • Ortho Clinical Diagnostics
  • Oxford Nanopore
  • Panagene
  • PerkinElmer
  • Primerdesign
  • Prominex
  • Qiagen (Statdx)
  • Quantumdx
  • Quest Diagnostics
  • Quidel
  • Randox Laboratories
  • Roche Molecular Diagnostics
  • Saw Diagnostics
  • SD Biosensor
  • Seegene
  • Sensovation
  • Siemens Healthineers (Fast Track Diagnostics)
  • SkylineDx
  • Sona Nanotech
  • T2 Biosystems
  • Thermo Fisher
  • Veredus Labs
  • Vircell
  • YD Diagnostics
  • Zhejiang Orient Gene Biotech

第6章 医療システムの診断需要の展望

  • 最良のケースでの需要
  • 予想されるケースでの需要
  • 最悪のケースでの需要

第7章 分子/血清学診断需要の展望

  • 最良のケースでの需要
  • 予想されるケースでの需要
  • 最悪のケースでの需要
図表

Table of Tables

  • Table 1: Who List of Potential Pandemic Pathogens
  • Table 2: Characteristics of Coronavirus Pandemic Infections
  • Table 3: COVID-19 Symptoms
  • Table 4: The Three Scenarios
  • Table 5: Test Consumption Outlook Based on Mid July Daily Run Rate - Relative Percentages per quarter
  • Table 6: Scenario 1 Assumptions
  • Table 7: Scenario 2 Assumptions
  • Table 8: Scenario 3 Assumptions
  • Table 9: Healthcare Dx Total Demand by Country - Best Case
  • Table 10: Healthcare Dx Total Met Demand by Country - Expected Case
  • Table 11: Healthcare Dx Total Demand by Country - Worst Case
  • Table 12: Molecular Dx Total Demand by Country - Best Case
  • Table 13: Molecular Dx Total Demand by Country - Expected Case
  • Table 14: Serology Dx Total Demand by Country - Expected Case
  • Table 15: Molecular Dx Total Demand by Country - Worst Case
  • Table 16: Serology Dx Total Demand by Country - Worst Case

List of Figures

  • Figure 1 Global Distribution Pandemic Preparedness
  • Figure 2: Global Pandemic Pathogen Status
  • Figure 3: Estimated Economic Impact of Viral Pandemic by Region
  • Figure 4: Historical Pandemics Infographic
  • Figure 5: Antigenic Drift Creates a new Strain of Virus
  • Figure 6: Structure of Coronaviruses
  • Figure 7: 1918 Flu - 2 Infection Curves
  • Figure 8: Global Healthcare Diagnostics Demand by Quarter - Best Case
  • Figure 9: Global Healthcare Diagnostics Demand by Quarter - Expected Case
  • Figure 10: Global Healthcare Diagnostics Demand by Quarter - Worst Case
  • Figure 11: Global Healthcare Diagnostics Molecular Demand by Quarter - Best Case
  • Figure 12: Global Healthcare Diagnostics Serology Demand by Quarter - Best Case
  • Figure 13: Global Healthcare Diagnostics Molecular Demand by Quarter - Expected Case
  • Figure 14: Global Healthcare Diagnostics Total Demand by Quarter - Expected Case
  • Figure 15: Global Healthcare Diagnostics Molecular Demand by Quarter - Best Case
  • Figure 16: Global Healthcare Diagnostics Serology Demand by Quarter - Worst Case
目次

Can diagnostics stop an epidemic? Rapid diagnostics is key to epidemic management. But the demand is staggering. Will it stagger the diagnostics industry? This report looks at the assay volume demands by country looking out 6 quarters to the end of 2021. We look at 3 scenarios for pandemic progression and explore diagnostics demand in each scenario. A breakout of Molecular and Serology is also included. As always, our analysts are available to breakout separate numbers to meet your needs and work with your assumptions.

Our forecasts are based on the WHO Health Security Index with specific assumptions about the effectiveness of distancing measures and the impact of health system overload on different countries. These create varying timelines of demand.

All report data is available in Excel format on request.

Make projections with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

i. COVID-19. Strategic Situation Analysis

ii. COVID-19. Guidance for Executives

iii. COVID-19. Guidance for Management Consultants and Investment Advisors

1. Introduction and Market Definition

  • 1.1. What are Pandemics?
  • 1.2. The Role of Zoonosis
  • 1.3. Market Definition
    • 1.3.1. Assay Volumes.
    • 1.3.2. Healthcare Systems Demand
    • 1.3.3. Molecular & Serology
  • 1.4. Methodology
    • 1.4.1. Authors
    • 1.4.2. Sources
  • 1.5. Historical Perspective on Pandemics
    • 1.5.1. HIV/AIDS PANDEMIC 2005-2012
    • 1.5.2. FLU PANDEMIC 1968
    • 1.5.3. ASIAN FLU 1956-1958
    • 1.5.4. SPANISH FLU 1918
    • 1.5.5. SIXTH CHOLERA PANDEMIC 1910-1911
    • 1.5.6. FLU PANDEMIC 1889-1890
    • 1.5.7. THE BLACK DEATH 1346-1353

2. The Pandemic Overview

  • 2.1. What is a Virus?
    • 2.1.1. Is a Virus Alive?
    • 2.1.2. Viral Structure
    • 2.1.3. The Viral Genome
    • 2.1.4. Viral Mutation
  • 2.2. The Coronavirus
    • 2.2.1. Severe acute respiratory syndrome (SARS)
    • 2.2.2. Middle East respiratory syndrome (MERS)
    • 2.2.3. COVID-19. The SARS CoV 2 Virus
      • 2.2.3.1. Signs and symptoms
      • 2.2.3.2. Transmission
      • 2.2.3.3. Diagnosis
      • 2.2.3.4. Prevention
      • 2.2.3.5. Management
      • 2.2.3.6. Prognosis
      • 2.2.3.7. A Note on Global Statistics Reporting
  • 2.3. Pandemic Diagnostics
    • 2.3.1. Risk Management-Spark and Spread
    • 2.3.2. Dx Technology-Nucleic Acid Based
    • 2.3.3. Dx Technology - Immunoassay
    • 2.3.4. Time to Market and Preparedness Issues

3. Infection/Hospitalization Projections by Country by Quarter. All Case Secenarios

  • 3.1. Scenarios Overview
    • 3.1.1. WHO Global Health Security Index
    • 3.1.2. Pandemic Progression Outlook Methodology
  • 3.2. Scenario 1. Best Case
  • 3.3. Scenario 2. Expected Case
  • 3.4. Scenario 3. Worst Case

4. Diagnostic Company Profiles

  • 1drop
  • Abbott Diagnostics
  • Accelerate Diagnostics
  • Ador Diagnostics
  • Advanced Biological Laboratories
  • Akkoni Biosystems
  • Altona Diagnostics
  • Alveo Technologies
  • Applied BioCode
  • Applied DNA Sciences
  • Anatolia Geneworks
  • Assurance Scientific Laboratories
  • Aus Diagnostics
  • Autobio Diagnostics
  • BD Diagnostics
  • BGI Genomics Co. Ltd
  • Biocartis
  • Biodesix
  • BioFire Diagnostics
  • Biolidics
  • bioMérieux
  • Bioneer
  • Bio-Rad Laboratories
  • BioReference Laboratories
  • Bosch Healthcare Solutions GmbH
  • Cepheid
  • Cerstest Biotec
  • Chembio Diagnostics
  • Color Genomics
  • Credo Diagnostics Biomedical
  • Curetis
  • Diagenode Diagnostics
  • Diascopic
  • Diasorin
  • Enzo Life Sciences, Inc.
  • Exact Sciences
  • Expedeon
  • Fulgent Genetics
  • Fusion Genomics.
  • Genedrive
  • GenePOC Diagnostics
  • Genetic Signatures
  • Genetron
  • GenMark Dx
  • Gold Standard Diagnostics
  • Hologic
  • Immunexpress
  • Inflammatix
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Laboratory Corporation of America
  • Lexagene
  • Luminex
  • Mayo Clinic Laboratories
  • Mbio Diagnostics
  • Meridian Bioscience
  • Mesa Biotech
  • Mobidiag
  • Nanomix
  • Novacyt
  • Orig3n
  • Ortho Clinical Diagnostics
  • Oxford Nanopore
  • Panagene
  • PerkinElmer
  • Primerdesign
  • Prominex
  • Qiagen (Statdx)
  • Quantumdx
  • Quest Diagnostics
  • Quidel
  • Randox Laboratories
  • Roche Molecular Diagnostics
  • Saw Diagnostics
  • SD Biosensor
  • Seegene
  • Sensovation
  • Siemens Healthineers (Fast Track Diagnostics)
  • SkylineDx
  • Sona Nanotech
  • T2 Biosystems
  • Thermo Fisher
  • Veredus Labs
  • Vircell
  • YD Diagnostics
  • Zhejiang Orient Gene Biotech

6. Healthcare Systems Dx Demand Outlook

  • 6.1. Healthcare System Demand by Country-Best Case
    • 6.1.1. Table-Healthcare Dx Total Demand by Country-Best Case
    • 6.1.3. Chart-Global Healthcare Dx Total Demand by Quarter-Best Case
  • 6.2. Healthcare System Demand by Country-Expected Case
    • 6.2.1. Table-Healthcare Dx Total Demand by Country-Expected Case
    • 6.2.3. Chart-Global Healthcare Dx Total Demand by Quarter-Expected Case
  • 6.3. Healthcare System Demand by Country-Worst Case
    • 6.3.1. Table-Healthcare Dx Total Demand by Country-Worst Case
    • 6.3.3. Chart-Global Healthcare Dx Total Demand by Quarter-Worst Case

7. Molecular/Serology Dx Demand Outlook

  • 7.1. Molecular/Serology Demand by Country-Best Case
    • 7.1.1. Table-Molecular Dx Total Demand by Country-Best Case
    • 7.1.2. Table-Serology Dx Total Demand by Country-Best Case
    • 7.1.3. Chart-Global Molecular Dx Total Demand by Quarter-Best Case
    • 7.1.4. Chart-Global Serology Dx Total Demand by Quarter-Best Case
  • 7.2. Molecular/Serology Demand by Country-Expected Case
    • 7.2.1. Table-Molecular Dx Total Demand by Country-Expected Case
    • 7.2.2. Table-Serology Dx Total Demand by Country-Expected Case
    • 7.2.3. Chart-Global Molecular Dx Total Demand by Quarter-Expected Case
    • 7.2.4. Chart-Global Serology Dx Total Demand by Quarter-Expected Case
  • 7.3. Molecular/Serology Demand by Country-Worst Case
    • 7.3.1. Table-Molecular Dx Total Demand by Country-Worst Case
    • 7.3.2. Table-Serology Dx Total Demand by Country-Worst Case
    • 7.3.3. Chart-Global Molecular Dx Total Demand by Quarter-Worst Case
    • 7.3.4. Chart-Global Serology Dx Total Demand by Quarter-Worst Case
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.